Your Ingredient Worked in the Trial. Why Hasn't the Food Manufacturer Ordered It?

The R&D team likes the samples. The product developer can see an application. Somebody calls the ingredient promising and asks for more information. Six months pass without an order. The startup hears that the industry moves slowly, so it makes a new deck and tries again.

The delay may have little to do with how clearly the ingredient's benefits were explained. The order depends on a wider set of conditions, including regulatory status, consistent supply, line compatibility, cost in the recipe, quality systems, shelf life and a product launch inside the customer that nobody has yet approved.

Our guide to positioning food tech for B2B buyers covers how to present readiness before a trial. This guide starts after a trial has passed. The task is to find which condition is still open and whether the company can change it.

One ingredient, five internal decisions

The same material reaches different people for different reasons.

These checks make up the decision. A startup often has a strong relationship with R&D and no access to the people holding the other four. The next conversation should help the champion name who owns each gate. Your Champion Said Yes gives the method for mapping each approver and marking which gates are open.

Find the launch the ingredient is waiting for

Your ingredient goes into the buyer's product, and that product has its own approval route. A reformulation or a new launch needs a brief, a budget, consumer testing and a slot in the manufacturer's launch calendar. If the product your ingredient was trialled in has no approved launch, the trial result waits with it.

Ask your R&D contact which product the ingredient is meant for, where that product sits in their own stage gates and when its next gate review falls. The answer may explain a long silence better than any feedback on the ingredient.

Write down what the trial proved

Record the result in operational terms.

A successful tasting and a qualified industrial application sit at different stages. A pilot on one line leaves the manufacturer's other facilities untested. Naming that keeps the achievement intact and shows the work that remains.

A result also belongs to its application. Christoph Pitter, co-founder of ProteinDistillery, which makes protein ingredients from brewer's yeast for food companies, described tailoring the protein to each use in a November 2023 interview with us. “Furthermore, we can customise the end product depending on what function our customers seek. For example, we can create a different protein for a meat alternative than a cheese alternative because they have different taste requirements.” A trial in one of those applications says little about the other, so the record names the application first.

The technical team keeps the nuance. In the commercial conversation, its job is to help the buyer see which decision the existing evidence can already support.

Put cost in use in the recipe

A procurement director may need the comparison in the finished recipe or process, with dose, yield, processing changes, waste, shelf life, supply reliability and the cost of qualifying a new supplier all included. How to Position Food Tech for B2B Buyers sets out what that case covers.

Share the model with its assumptions and a named owner. Label an indicative cost as indicative, and keep a price at future scale apart from the price available today. If the comparison is fair and the numbers fail, a new deck leaves the arithmetic where it was. If the numbers work and the comparison is hard to follow, a clearer explanation helps the champion carry it.

Ask for a commitment the evidence can carry

A food manufacturer may be far from a large supply agreement and ready to approve a staged programme with clear success criteria, costs and responsibilities. That might be samples for a defined formulation, a line test under agreed conditions, a review of technical documentation or a limited commercial evaluation.

Match the request to the evidence. A request for offtake while supply and qualification remain uncertain comes too early. Exploratory trials repeated with no decision gate use both sides' time and move nothing. Each stage proposal records what the stage tests, how success is judged, who approves the move forward and what happens if the test fails. The Pilot Worked. What Belongs in the Commercial Proposal? sets out the full proposal.

If the platform could serve several ingredient markets, the choice of first application comes before any of this. Choosing the first market for a platform technology covers that decision, and the brand follows it.

Take the gate into your next buyer call

Ask the customer to name the first open approval, the person who owns it, the evidence it needs and the date it could be reviewed. Then write the next proposal around that gate. If nobody can name it, the trial showed technical interest and the commercial process has yet to start.

When the gate is evidence or economics, that is the work. When the evidence is sufficient and the buyer still cannot understand, justify or carry the case internally, the problem sits in the communication, and our biotech branding work positions food and industrial biotech companies around the application the buyer recognises, with the science as the evidence behind it.

Questions people ask

How do we explain formulation compatibility to food manufacturers?

Translate compatibility into practical tests, such as processing temperature, pH, texture, flavour, stability, dose and any other requirement of the application. State which have been tested and by whom. Keep the word “drop-in” for the formulations where it has been shown.

What does a technical buyer need before requesting samples?

Enough to make an informed request. That means the function, a typical application, the material specifications, the product's status, a suggested testing scope, the relevant safety documentation and a route to the technical team. If supply is limited to research samples, say so on the request form, so the form makes no promise of commercial availability.

How do we turn an ingredient trial into a case study?

Explain the customer's application and objective, what the trial tested, the measured outcome, its limits and the next step. Get permission before you publish technical data or the customer's name. A trial case should make a second buyer's evaluation easier to defend, and it should describe the first buyer's position as a trial.

How can one website serve R&D and sourcing teams?

Give R&D application and formulation pages, technical specifications, sample routes and evidence. Give sourcing teams quality systems, capacity, compliance and a commercial contact. Separate the two routes and keep one set of facts about readiness across both.

Sources and further reading

• How to Position Food Tech for B2B Buyers, Brighter Future, 2026
• Christoph Pitter, ProteinDistillery, founder interview, Brighter Future, 2023
• What Is Industrial Biotechnology?, Brighter Future, 2026
• Technology vs Product, Brighter Future, 2026
• Brand and investor narrative for food and industrial biotech, Brighter Future